Slice | Island | ||||||
---|---|---|---|---|---|---|---|
Treatment Group | Stage of Experiment | n | Frequency (bursts·sec-1) | Amplitude | n | Frequency (bursts·sec-1) | Amplitude |
aCSF control | 1. Baseline | 12 | 0.33 ± 0.02 | 2.01 ± 0.24 | 9 | 0.37 ± 0.04 | 1.39 ± 0.25 |
2. aCSF | 0.33 ± 0.03 | 2.03 ± 0.25 | 0.36 ± 0.04 | 1.50 ± 0.31 | |||
3. NCPA | 0.24 ± 0.03 | 2.13 ± 0.24 | 0.26 ± 0.04a, b | 1.57 ± 0.40 | |||
4. DPCPX | 0.31 ± 0.02 | 1.81 ± 0.22 | 0.37 ± 0.03 | 1.48 ± 0.44 | |||
Bicuculline | 1. Baseline | 11 | 0.36 ± 0.03 | 1.65 ± 0.23 | 7 | 0.44 ± 0.06 | 1.13 ± 0.19 |
2. Bicuculline | 0.33 ± 0.02 | 2.27 ± 0.35a | 0.43 ± 0.05 | 1.77 ± 0.29a | |||
3. NCPA | 0.22 ± 0.03a, b | 2.33 ± 0.35a | 0.41 ± 0.05 | 1.55 ± 0.21a | |||
4. DPCPX | 0.31 ± 0.03 | 1.93 ± 0.30 | 0.48 ± 0.07 | 1.81 ± 0.37a | |||
Gabazine | 1. Baseline | 7 | 0.34 ± 0.07 | 3.10 ± 1.14 | 6 | 0.27 ± 0.04 | 0.89 ± 0.10 |
2. Gabazine | 0.33 ± 0.06 | 3.48 ± 1.24 | 0.29 ± 0.03 | 0.86 ± 0.10 | |||
3. NCPA | 0.25 ± 0.07a, b | 2.56 ± 0.89 | 0.18 ± 0.05a, b | 0.89 ± 0.15 | |||
4. DPCPX | 0.32 ± 0.06 | 3.37 ± 1.11 | 0.30 ± 0.05 | 0.76 ± 0.09 | |||
Gabazine & Strychnine | 1. Baseline | 8 | 0.33 ± 0.05 | 0.97 ± 0.16 | 6 | 0.40 ± 0.06 | 1.15 ± 0.16 |
2. Gabazine + Strychnine | 0.30 ± 0.04 | 1.40 ± 0.20 | 0.40 ± 0.05 | 1.46 ± 0.23a | |||
3. NCPA | 0.24 ± 0.03a, b | 1.31 ± 0.23 | 0.34 ± 0.05 | 1.51 ± 0.26a | |||
4. DPCPX | 0.30 ± 0.03 | 1.10 ± 0.17 | 0.38 ± 0.04 | 1.45 ± 0.26a |